Devin Haddad is a Cardiology physician. OpenAlex indexes 31 publications with 417 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1005 Grove Rd
Greenville, SC 296054630
Telephone
864-522-8603Provider last certified this registry record 28 Aug 2023.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202516 payments
- Amgen Inc.Program year202511 payments
- Boston Scientific CorporationProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.8%Beta blocker15.8%Metoprolol Succinate47%Carvedilol34%Metoprolol Tartrate20%Part D≥47 patientsStatin14.4%Atorvastatin Calcium47%Rosuvastatin Calcium46%Pravastatin Sodium7%Part D<11 patients+ 12 more classes in this area
Blood & clotting
15.9%Factor Xa inhibitor12.3%Eliquis92%Xarelto8%Part D<11 patientsP2Y12 inhibitor3.6%Clopidogrel75%Prasugrel Hcl25%Part D<11 patientsMetabolism & gastrointestinal
1.3%SGLT2 inhibitor1.3%Jardiance100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MYOCARDIAL INJURY AFTER IBRUTINIB INITIATION FOR HEMATOLOGIC MALIGNANCIES
Journal of the American College of Cardiology
2022 - 497 Coronary Artery Calcification On CT Pulmonary Angiograms; Prevalence, Frequency Of Reporting And Impact On Clinical Management - A Single Center Tertiary Hospital Experience
Journal of cardiovascular computed tomography
2022 - Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma
Journal for ImmunoTherapy of Cancer
2021 - Cardiovascular Toxicity and Clinical Outcomes Following Chimeric Antigen Receptor T-Cell Infusion (CART) for Lymphoid Malignancies
Biology of Blood and Marrow Transplantation
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”